Résistance de Leishmania infantum au Glucantime®: circonstances de survenue et prise en charge thérapeutique
- 30 April 1996
- journal article
- case report
- Published by Elsevier in Archives de Pédiatrie
- Vol. 3 (4) , 352-356
- https://doi.org/10.1016/0929-693x(96)84691-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Epidemic Visceral Leishmaniasis in Sudan: A Randomized Trial of Aminosidine plus Sodium Stibogluconate versus Sodium Stibogluconate AloneThe Journal of Infectious Diseases, 1993
- Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages.Journal of Clinical Investigation, 1993
- Mechanisms of drug resistance in LeishmaniaParasitology Today, 1993
- Practical progress and new drugs for changing patterns of leishmaniasisParasitology Today, 1993
- Is leishmaniasis ever cured?Transactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Immunologic Markers of Clinical Evolution in Children Recently Infected with Leishmania donovani chagasiThe Journal of Infectious Diseases, 1992
- Response to Chemotherapy in Experimental Visceral Leishmaniasis: T Cell-Dependent but Interferon- - and Interleukin-2-IndependentThe Journal of Infectious Diseases, 1991
- Visceral leishmaniasis in patients infected with human immunodeficiency virusJournal of Infection, 1990
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Interferon-γ: Producer cells, activation stimuli, and molecular genetic regulationPharmacology & Therapeutics, 1990